Anaerobic Bacteremias in Left Ventricular Assist Devices and Advanced Heart Failure
Left ventricular assisted devices (LVADs) have revolutionized the treatment of advanced heart failure, providing meaningful increases in survival, functional capacity, and quality of life. There are two categories of LVADs patients: (1) bridge-to-transplant and (2) destination therapy. Advanced hear...
Saved in:
Main Authors: | David R. Murillo-Garcia, Julian Galindo, Natalia Pinto, Gabriel Motoa, Esther Benamu, Carlos Franco-Paredes, Daniel B. Chastain, Andrés F. Henao-Martínez |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Case Reports in Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/2019/7571606 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of bridging with left ventricular assist device on right ventricular function following heart transplantation
by: Annika Ingvarsson, et al.
Published: (2022-06-01) -
Use of Procalcitonin to Guide Discontinuation of Antimicrobial Therapy in Patients with Persistent Intra-Abdominal Collections: A Case Series
by: Gabriel Motoa, et al.
Published: (2020-01-01) -
Brain atrophy in heart failure patients following left ventricular assist device implantation or heart transplantation
by: D.Alan Herbst, MD, et al.
Published: (2025-02-01) -
Experience with left ventricular assist device usage in the treatment of end-stage heart failure
by: B.M. Todurov, et al.
Published: (2017-06-01) -
Current Trends in Implantable Left Ventricular Assist Devices
by: Jens Garbade, et al.
Published: (2011-01-01)